국제약품 Stock: price and insider trades · South Korea

국제약품 is a Health Care company. Its directors and officers file their transactions with DART (FSS). From 31 October 2025 to 31 October 2026, the disclosure feed for 국제약품 logged 7 filings by 5 insiders.

Not one open-market sale was filed. On the buying side, 4 insiders reported 6 purchases totalling €4,441. The totals do not cover 5 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 김영관 filed the largest purchase, €4,441, on 29 May 2026. Those buying include 3 senior executives and 1 major shareholder.

For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 7 filings here. Since 2021, the database holds 57 purchases and 2 sales by insiders of the company.

The last insider purchase was made public on 10 July 2026, 123 days ago. Filings reach the DART (FSS) feed a median of 4 days after the trade. This delay matters because a trade only becomes useful information once it is public.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.